From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D plus all-trans retinoic acid plus Temozolomide combination in treatment of GBM

Ilhan Elmaci; Aysel Ozpinar; Alp Ozpinar; Jennifer L. Perez; Meric A. Altinoz

doi:10.1007/s11011-019-00412-5

From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D plus all-trans retinoic acid plus Temozolomide combination in treatment of GBM

Ilhan Elmaci, Aysel Ozpinar, Alp Ozpinar, Jennifer L. Perez, Meric A. Altinoz^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › Academic › peer-review

Original language	English
Pages (from-to)	687-704
Number of pages	18
Journal	Metabolic Brain Disease
Volume	34
Issue number	3
DOIs	https://doi.org/10.1007/s11011-019-00412-5
Publication status	Published - Jun 2019

Keywords

Glioblastoma
Glioma
Vitamin D
Vitamin a
Temozolomide
NERVE GROWTH-FACTOR
NEUROTROPHIC FACTOR GDNF
D-RECEPTOR EXPRESSION
1,25-DIHYDROXYVITAMIN D-3
BRAIN-TUMOR
CELL-DEATH
C6 GLIOMA
PHASE-II
MEDROXYPROGESTERONE ACETATE
CANCER

Cite this

Elmaci, I., Ozpinar, A., Ozpinar, A., Perez, J. L., & Altinoz, M. A. (2019). From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D plus all-trans retinoic acid plus Temozolomide combination in treatment of GBM. Metabolic Brain Disease, 34(3), 687-704. https://doi.org/10.1007/s11011-019-00412-5

Elmaci, Ilhan ; Ozpinar, Aysel ; Ozpinar, Alp ; Perez, Jennifer L. ; Altinoz, Meric A. / From epidemiology and neurometabolism to treatment : Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D plus all-trans retinoic acid plus Temozolomide combination in treatment of GBM. In: Metabolic Brain Disease. 2019 ; Vol. 34, No. 3. pp. 687-704.

@article{cb94908017e8446e9d487e060d4ca65c,

title = "From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D plus all-trans retinoic acid plus Temozolomide combination in treatment of GBM",

keywords = "Glioblastoma, Glioma, Vitamin D, Vitamin a, Temozolomide, NERVE GROWTH-FACTOR, NEUROTROPHIC FACTOR GDNF, D-RECEPTOR EXPRESSION, 1,25-DIHYDROXYVITAMIN D-3, BRAIN-TUMOR, CELL-DEATH, C6 GLIOMA, PHASE-II, MEDROXYPROGESTERONE ACETATE, CANCER",

author = "Ilhan Elmaci and Aysel Ozpinar and Alp Ozpinar and Perez, {Jennifer L.} and Altinoz, {Meric A.}",

year = "2019",

month = jun

doi = "10.1007/s11011-019-00412-5",

language = "English",

volume = "34",

pages = "687--704",

journal = "Metabolic Brain Disease",

issn = "0885-7490",

publisher = "Springer",

number = "3",

}

Elmaci, I, Ozpinar, A, Ozpinar, A, Perez, JL & Altinoz, MA 2019, 'From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D plus all-trans retinoic acid plus Temozolomide combination in treatment of GBM', Metabolic Brain Disease, vol. 34, no. 3, pp. 687-704. https://doi.org/10.1007/s11011-019-00412-5

From epidemiology and neurometabolism to treatment : Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D plus all-trans retinoic acid plus Temozolomide combination in treatment of GBM. / Elmaci, Ilhan; Ozpinar, Aysel; Ozpinar, Alp; Perez, Jennifer L.; Altinoz, Meric A.

In: Metabolic Brain Disease, Vol. 34, No. 3, 06.2019, p. 687-704.

Research output: Contribution to journal › Review article › Academic › peer-review

TY - JOUR

T1 - From epidemiology and neurometabolism to treatment

T2 - Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D plus all-trans retinoic acid plus Temozolomide combination in treatment of GBM

AU - Elmaci, Ilhan

AU - Ozpinar, Aysel

AU - Ozpinar, Alp

AU - Perez, Jennifer L.

AU - Altinoz, Meric A.

PY - 2019/6

Y1 - 2019/6

KW - Glioblastoma

KW - Glioma

KW - Vitamin D

KW - Vitamin a

KW - Temozolomide

KW - NERVE GROWTH-FACTOR

KW - NEUROTROPHIC FACTOR GDNF

KW - D-RECEPTOR EXPRESSION

KW - 1,25-DIHYDROXYVITAMIN D-3

KW - BRAIN-TUMOR

KW - CELL-DEATH

KW - C6 GLIOMA

KW - PHASE-II

KW - MEDROXYPROGESTERONE ACETATE

KW - CANCER

U2 - 10.1007/s11011-019-00412-5

DO - 10.1007/s11011-019-00412-5

M3 - Review article

VL - 34

SP - 687

EP - 704

JO - Metabolic Brain Disease

JF - Metabolic Brain Disease

SN - 0885-7490

IS - 3

ER -

Access to Document

10.1007/s11011-019-00412-5